Aegerion Pharmaceuticals (AEGR) Names Craig E. Fraser as President, U.S.
Tweet
Share
E-mailGet Alerts AEGR Hot Sheet
Join SI Premium – FREE
Aegerion Pharmaceuticals, Inc. (Nasdaq: AEGR) announced the appointment of Craig E. Fraser as President, U.S.
Mr. Fraser was most recently Vice President, Global Disease Areas at Pfizer Inc. (NYSE: PFE) responsible for the commercial development and global marketing for the Specialty Cardiovascular, Anti-Bacterial, Anti-Fungal, Gastrointestinal and Anti-Viral disease areas, where he managed a portfolio of six products totaling over three billion dollars in revenue and multiple new products in development.
Mr. Fraser was most recently Vice President, Global Disease Areas at Pfizer Inc. (NYSE: PFE) responsible for the commercial development and global marketing for the Specialty Cardiovascular, Anti-Bacterial, Anti-Fungal, Gastrointestinal and Anti-Viral disease areas, where he managed a portfolio of six products totaling over three billion dollars in revenue and multiple new products in development.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- European Commission Approves Pfizer’s EMBLAVEO® for Patients with Multidrug-Resistant Infections and Limited Treatment Options
- Ziff Davis (ZD) Appoints Kate Gutman as EVP, GM of Technology Media Businesses
- PENN Entertainment (PENN) Names Aaron LaBerge Chief Technology Officer
Create E-mail Alert Related Categories
Management ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
